For citations:
Kuzmin O.B., Buchneva N.V., Belyanin V.V., Zhezha V.V., Stolbova M.V. Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension. Rational Pharmacotherapy in Cardiology. 2024;20(4):451-459. (In Russ.) https://doi.org/10.20996/1819-6446-2024-3064. EDN: KAQZDN